Henry Townsing Sells 100,000 Shares of Vita Life Sciences Limited (ASX:VLS) Stock

Vita Life Sciences Limited (ASX:VLSGet Free Report) insider Henry Townsing sold 100,000 shares of the company’s stock in a transaction on Friday, April 12th. The shares were sold at an average price of A$2.10 ($1.35), for a total value of A$210,000.00 ($135,483.87).

Henry Townsing also recently made the following trade(s):

  • On Wednesday, March 27th, Henry Townsing 300,000 shares of Vita Life Sciences stock.

Vita Life Sciences Price Performance

The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.57 and a current ratio of 2.98.

Vita Life Sciences Increases Dividend

The business also recently announced a Final dividend, which was paid on Thursday, April 11th. Stockholders of record on Thursday, April 11th were issued a dividend of $0.06 per share. This is a positive change from Vita Life Sciences’s previous Final dividend of $0.03. This represents a dividend yield of 2.6%. The ex-dividend date was Thursday, March 21st. Vita Life Sciences’s dividend payout ratio is 52.94%.

About Vita Life Sciences

(Get Free Report)

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, and Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritional products and nutritional oils; immunity; hair, skin, and nails; liver and digestion; weight management; cardiovascular health; pain and inflammation; men, women, and children's health; antioxidant; and bones and joints.

Read More

Receive News & Ratings for Vita Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vita Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.